Skip to main content
. 2022 Jul 27;128(3):649–670. doi: 10.1152/jn.00205.2022

Table 1.

Participant characteristics for transcutaneous and epidural stimulation studies focusing on autonomic, motor, or autonomic and motor outcomes

Study [T or E] Number of Participants Gender Age, Yr Injury Duration, Yr AIS Classification, n Level of Injury Study Type
Sachdeva et al. (23) [T1]† 1 1 M 37 3 A C4 CR
Wu et al. (24) [T2]‡ 13 10 M, 3 F 21–65 1–20 B:3, C:5, D:5 C2–C8 CS
Sayenko et al. (25) [T3]‡ 15 12 M, 3 F 23–53 2–13 A:11 B:1 C:3 C4–T12 DBCO
Gad et al. (26) [T4]‡ 6 5 M, 1 F 20–62 1–21 B:2, C:4 C4:3, C6:2, C8:1 CS
Phillips et al. (20) [T5]† 5 4 M, 1 F 23–32 3+ A:3, B:2 C5–C6, T2 CS
Gad et al. (27) [T6]§ 1 1 M 35–40 7 A T9, L1 (V) CRCO
Murray and Knikou (28) [T7]‡ 1 1 M 27 9 C (UL), B (LL) C6/C7 CR
Shelyakin et al. (29) [T]‡ 25 N R NR NR, chronic NR NR CS
Squair et al. (30) [E]† 1 1 M 38 1 A C5 CR
Darrow et al. (31) [E]† 2 2 F 48, 52 5, 10 A T4, T8 CS
Nightingale et al. (19) [E]† 1 1 M 33 5 B C5 CR
Aslan et al. (32) [E]† 7 7 M 26.7 + 4.1 2–3.5 A:4, B:3 C5–T4 PAR
DiMarco et al. (33) [E]§ 1 1 M 50 2 NR C4 CR
Harkema et al. (15) [E]† 4 3 M, 1 F 24–35 3.8–8 A:3, B:1 C4 CS
West et al. (34) [E]† 1 1 M Early 30s Chronic, >1 B C5 CR
Edgerton and Harkema (35) [E]‡ 1 1 M 23 >3.5 B C7–T1 CR
Ganley et al. (36) [E]‡ 2 2 M 43; 48 3.5; 8 C C5–C6, T8 CS
Carhart et al. (37) [E]‡ 1 1 M 43 3.5 C C5–C6 CR
Herman et al. (16) [E]‡ 1 1 M 43 3.5 C C5–C6 CR

Numbers 1 through 7 correspond to anode and cathode electrode positions as shown on the body image in Fig. 3A. All spinal levels are neurological level of injury, unless indicated otherwise with V for vertebral. n refers to number of persons with each American Spinal Injury Association impairment scale (AIS) classification when studies include multiple participants. †Autonomic outcome; ‡motor outcome; §autonomic and motor outcome. CR, case report; CRCO, case report, cross over design; CS, case series; DBCO, double blind crossover; E, epidural; LL, lower limbs; NR, not reported; PAR, parallel group design; T, transcutaneous; TSCS, transcutaneous spinal cord stimulation; UL, upper limbs; V, vertebral.